PREMs In Vascular SurgERy Enhancement Study

Surgery Clinical Trial

— PREMIERE  

Official title:

Patient-Reported Experience Measures in Vascular Surgery Enhancement Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06363175
• Other study ID #: 8737
• Secondary ID: 343073
• Status: Not yet recruiting
• Start date: June 1, 2024
• Est. completion date: June 1, 2026

Study information

• Verified date: April 2024
• Source: Cardiff and Vale University Health Board
• Contact: Maram Darwish, MD
• Phone: +447841582039
• Email: maram.darwish[@]wales.nhs.uk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

THE PROBLEM: Patient Reported Experience Measures (PREMs) ask patients about their healthcare service experience. It gives them a voice to share their views. PREMs allow healthcare providers (HCPs) to see where care is good, and where they could improve. Vascular surgery is a surgical speciality looking after people's blood vessels (arteries and veins). There is no PREM available for vascular patients. The research team want to create a PREM for this patient group. WHY IT IS IMPORTANT: A PREM allows HCPs to record and understand patients' experiences of their treatment. It gives patients a way to provide feedback on their healthcare experience. PREMs can help HCPs make changes to patients' care, identifying areas of good practice and areas for improvement. The Welsh Government is keen to support the use of PREMs. AIMS: To develop a PREM specific to vascular surgery patients. RESEARCH PLAN: The research team will summarise the literature about PREMs in surgery. The research team will then run focus groups and interviews with patients and staff to create a 'draft' PREM for vascular patients in Wales. The 'draft' PREM will be translated into Welsh. In the second phase, a larger number of vascular patients (100-300 depending on how long the 'draft' PREM is) from hospitals across Wales will complete the questionnaire. Statistical tests will look at the results to see if the questionnaire works well to capture patients' experiences. Based on these results, small changes will be made to make the 'draft' PREM better. This will make sure the 'final PREM' is ready for widespread use in Wales and beyond. PATIENT AND PUBLIC INVOLVEMENT: The patients' experience team at CAVUHB has reviewed our patients' materials. Our research team includes PPI co-applicants (DC and AH). DC a double amputee who has had many vascular operations. DC has experience raising awareness about vascular disease through public forums like the Limbless Association Charity and BBC Radio Wales. AH has issues with her leg due to smoking and had a keyhole operation to help with that. She had some problems after the procedure This is her first time as a PPI representative. DC and AH supported our research design and will be steering group members. Also, our research focuses on giving patients a voice and will include patients across Wales. A diverse group of patients will be involved across all stages of the PREM development.

Description:

Background: PREMs have emerged as instruments designed to capture patients' experiences of their healthcare journey. No PREMs have been developed or validated to be used among vascular surgery patients specifically. Objectives: To develop and validate a PREM specific to vascular surgery, assessing the patient's experience and satisfaction with their care and treatment. Study design and methods: Patient Reported Experience Measures In Vascular Surgery Enhancement Study (PREMIERE) is a multi-site sequential mixed-methods cohort design, incorporating qualitative and quantitative approaches in two phases. The first phase will focus on developing a draft PREM for vascular surgery patients, while the second phase will aim to validate the draft PREM to create a 'final PREM'. Patient inclusion criteria are: (i) age ≥18 ; (ii) have undergone a vascular procedure (iii) experienced an inpatient vascular care within the previous 3 months; (iv) not cognitively impaired; (v) willing and able to provide written consent for participation; (vi) able to communicate in English or Welsh. Statistical analysis: For the qualitative phase, inductive thematic analysis will be carried out using the non-numerical data analysis for Windows software NVivo . For quantitative data, psychometric tests such as item analysis, internal consistency, construct validity, and principal component analysis with varimax rotation will be used to extract factors. Quantitative data will be analysed using IBM SPSS Statistics (Version 27) software. Anticipated impact: PREMIERE will contribute to the development of a robust and context-specific PREM for vascular patients. This PREM will provide a valuable tool for assessing and improving the in-patient vascular surgery pathway, including pre-operative, peri-operative, and post-operative phases. Also, the utilization of a robust vascular PREM presents a transformative opportunity to benchmark and enhance the performance of vascular units.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 330
• Est. completion date: June 1, 2026
• Est. primary completion date: August 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who have recently (within the last three months) undergone a vascular procedure or intervention under the care of a vascular surgery team in the inpatient setting.
• Adults aged 18 years or older
• Not cognitively impaired (as determined by medical reports and/or self-reporting).
• Willing and able to provide written consent for participation.
• Able to speak, read and write English or Welsh

Exclusion Criteria:

• Patients who lack capacity or suffer from cognitive impairment.
• Patients who are unable to speak, read and write English or Welsh.

Related Conditions & MeSH terms

• Patient Empowerment
• Patient Engagement
• Patient Satisfaction
• Surgery
• Vascular Diseases

Locations

Country	Name	City	State
United Kingdom	Southeast Wales Vascular Network-Cardiff and Vale University Health Board	Cardiff	Wales

Sponsors (3)

Lead Sponsor	Collaborator
Cardiff and Vale University Health Board	Centre for Healthcare Evaluation, Device Assessment, and Research (CEDAR), Welsh Value in Health Centre (WViHC)

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Degree of Validity of the PREM	Validity: The extent to which a measure assesses what it intends to measure.	Day 0, Day 30
Primary	Degree of Reliability of the PREM	Reliability: The consistency and stability of a measure over time and across different conditions.	Day 0, Day 30
Primary	Degree of Responsiveness of the PREM	Responsiveness: The ability of a measure to detect change over time in the concept being measured.	Day 0, Day 30
Primary	Degree of Feasibility of implementing the PREM in clinical practice	Feasibility: The practicality and suitability of implementing a measure in a specific setting or context.	Day 0, Day 30